Dr. Reginald Dwain Gladish, MD

Dr. Gladish practices at Athens Dialysis in Huntsville, Alabama.

Dr. Gladish's NPI, 1831167287, was assigned on March 10, 2006. Dr. Gladish graduated from LSU Health Shreveport School of Medicine in 1993. Dr. Gladish's Alabama license number on file is 18219.

Dr. Gladish's primary practice is Athens Dialysis, at 810 Franklin SE St, Huntsville, AL 35801 in Madison County. The practice phone is (256) 233-4730.

Dr. Gladish's primary practice is Athens Dialysis in Huntsville, Alabama. Dr. Gladish is also affiliated with Decatur Morgan Hospital. The medical group on file is Nephrology of North Alabama. Dmand AI also links Dr. Gladish to 1 more hospital and 5 dialysis centers, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gladish practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Gladish's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Gladish is board certified in internal medicine by the American Board of Internal Medicine. Dr. Gladish has a license on file in Alabama.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, gout and kidney disease among the conditions Dr. Gladish treats.

CMS data shows 3,921 Medicare services from Dr. Gladish across 14 procedure codes in 2024, for 674 Medicare patients. Medicare paid $324,426 for them.

CMS counts 674 Medicare patients who saw Dr. Gladish in 2024. The largest group is 75 to 84, with 276 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 3.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gladish's median patient age at 73, with 54% women.

In 2024, Dr. Gladish wrote 2,713 Medicare Part D claims for 412 patients. 90% of them were for generic drugs. CMS names the drug for 2,349 of them, across 54 drugs with 11 or more claims each, at $227,367 in total drug cost. In 2023, CMS named 2,322 claims across 51 drugs.

Dr. Gladish accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Gladish, published from 2021 to 2025. 2023 was the busiest year, with 2. The most frequent topics are COVID-19, COVID-19 Vaccines and Immunogenicity, Vaccine. Dr. Gladish has published most often in Am J Kidney Dis. Dr. Gladish's most frequent co-authors are Kenneth Dominic Abreo, MBBS, Christos P. Argyropoulos, MD, PhD and Eduardo K. Lacson, MD, MPH.

CMS Open Payments shows 295 general payments to Dr. Gladish from 30 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 51% of the total. Outset Medical Inc paid the most, $10,050.

Dmand AI lists 1 award for Dr. Gladish, most recently CMS Stage 1 2012 in 2011.

Dr. Gladish graduated from LSU Health Shreveport School of Medicine in 1993. Dr. Gladish is a member of ACP.

Dr. Gladish is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.